drugs glp-1 Medications: Everything You Need to Know GLP-1 Medications Show Promise as
Description
These findings strongly suggest that SGLT2 inhibitors confer cardiovascular and renal protection through mechanisms independent of glycemic improvement
Cheng, Y
276 Additionally, tri-agonist treatment resulted in apoptosis, synaptic loss, inflammation, amyloid levels and oxidative stress being reduced
As these drugs gain momentum, we know we could see a rapid increase for their demand, given their potential to treat many different indications
Will future trials truly reflect the diverse communities that carry the highest burden of obesity, sleep apnea and cardiometabolic disease
doi: 10.1161/HYPERTENSIONAHA.109.130203 31 HermidaRCCrespoJJDominguez-SardinaMOteroAMoyaARiosMTet al
